Genetic characterization, current model systems and prognostic stratification in PAX fusion-negative vs. PAX fusion-positive rhabdomyosarcoma

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

Hettmer, S
Linardic, CM
Kelsey, A
Rudzinski, ER
Vokuhl, C
Selfe, J
Ruhen, O
Shern, JF
Khan, J
Kovach, AR
Lupo, PJ
Gatz, SA
Schäfer, BW
Volchenboum, S
Minard-Colin, V
Koscielniak, E
Hawkins, DS
Bisogno, G
Sparber-Sauer, M
Venkatramani, R
Merks, JHM
Shipley, J

September 2022

Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas in children/adolescents less than ...

t(11;22)(q24;q12) in rhabdomyosarcomas (RMS)

Huret, JL

January 2011

Review on t(11;22)(q24;q12) in rhabdomyosarcomas (RMS), with data on clinics, and the genes involved

Soft tissue tumors: Rhabdomyosarcoma

Couturier, J

January 1998

Review on Soft tissue tumors: Rhabdomyosarcoma, with data on clinics, and the genes involved

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Carina A. Dehner
Amy E. Armstrong
Marielle Yohe
Jack F. Shern
Angela C. Hirbe

September 2021

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents and accoun...

Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.

Walther, Charles
Mayrhofer, Markus
Nilsson, Jenny
Hofvander, Jakob
Jonson, Tord
Mandahl, Nils
Øra, Ingrid
Gisselsson Nord, David
Mertens, Fredrik

January 2016

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents. Alveolar ...

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Missiaglia, E.
Williamson, D.
Chisholm, J.
Wirapati, P.
Pierron, G.
Petel, F.
Concordet, J.P.
Thway, K.
Oberlin, O.
Pritchard-Jones, K.
Delattre, O.
Delorenzi, M.
Shipley, J.

January 2012

PURPOSE: To improve the risk stratification of patients with rhabdomyosarcoma (RMS) through the use ...

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

Hettmer, Simone
Linardic, Corinne M
Kelsey, Anna
Rudzinski, Erin R
Vokuhl, Christian
Selfe, Joanna
Ruhen, Olivia
Shern, Jack F
Khan, Javed
Kovach, Alexander R
Lupo, Philip J
Gatz, Susanne A
Schäfer, Beat W
Volchenboum, Samuel
Minard-Colin, Véronique
Koscielniak, Ewa
Hawkins, Douglas S
Bisogno, Gianni
Sparber-Sauer, Monika
Venkatramani, Rajkumar
Merks, Johannes H M
Shipley, Janet

September 2022

Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas in children/adolescents less than ...

Clonality and evolutionary history of rhabdomyosarcoma.

Chen, L
Shern, JF
Wei, JS
Yohe, ME
Song, YK
Hurd, L
Liao, H
Catchpoole, D
Skapek, SX
Barr, FG
Hawkins, DS
Khan, J

April 2022

To infer the subclonality of rhabdomyosarcoma (RMS) and predict the temporal order of genetic events...

Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.

Hingorani, P.
Missiaglia, E.
Shipley, J.
Anderson, J.R.
Triche, T.J.
Delorenzi, M.
Gastier-Foster, J.
Wing, M.
Hawkins, D.S.
Skapek, S.X.

January 2015

PURPOSE: Pediatric rhabdomyosarcoma (RMS) has two common histologic subtypes: embryonal (ERMS) and a...

Impact of fusion gene status versus histology on riskâ stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials

Selfe, Joanna
Olmos, David
Al‐saadi, Reem
Thway, Khin
Chisholm, Julia
Kelsey, Anna
Shipley, Janet

July 2017

BackgroundLongâ term toxicities from current treatments are a major issue in paediatric cancer. Pre...

Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies

Hettmer, S.
Li, Z.
Billin, A. N.
Barr, F. G.
Cornelison, D. D.
Ehrlich, A. R.
Guttridge, D. C.
Hayes-Jordan, A.
Helman, L. J.
Houghton, P. J.
Khan, J.
Langenau, D. M.
Linardic, C. M.
Pal, R.
Partridge, T. A.
Pavlath, G. K.
Rota, R.
Schafer, B. W.
Shipley, J.
Stillman, B.
Wexler, L. H.
Wagers, A. J.
Keller, C.

November 2014

Rhabdomyosarcoma (RMS) represents a rare, heterogeneous group of mesodermal malignancies with skelet...

Rhabdomyosarcoma (RMS): Insights into Epidemiology, Molecular Classification, Therapeutic Advances, and Future Directions

Cardenas Aguirre, Carlos Alberto

October 2023

Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, represents a formidable cha...

Rhabdomyosarcoma: Current challenges and their implications for developing therapies

Hettmer, Simone
Li, Zhizhong
Billin, Andrew N
Barr, Frederic G
Cornelison, D D W
Ehrlich, Alan R
Guttridge, Denis C
Hayes-Jordan, Andrea
Helman, Lee J
Houghton, Peter J
Khan, Javed
Langenau, David M
Linardic, Corinne M
Pal, Ranadip
Partridge, Terence A
Pavlath, Grace K
Rota, Rossella
Schäfer, Beat W
Shipley, Janet
Stillman, Bruce
Wexler, Leonard H
Wagers, Amy J
Keller, Charles

January 2014

Rhabdomyosarcoma (RMS) represents a rare, heterogeneous group of mesodermal malignancies with skelet...

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis A Report from the Children's Oncology Group

Davicioni, Elai
Anderson, Michael J.
Finckenstein, Friedrich Graf
Lynch, James C.
Qualman, Stephen J.
Shimada, Hiroyuki
Schofield, Deborah E.
Buckley, Jonathan D.
Meyer, William H.
Sorensen, Poul H.B.
Triche, Timothy J.

February 2009

Rhabdomyosarcoma (RMS) in children occurs as two major histological subtypes, embryonal (ERMS) and a...

Current and future treatment strategies for rhabdomyosarcoma

Chen, C.
Dorado-Garcia, H.
Scheer, M.
Henssen, A.G.

December 2019

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, and can be subcategorized...

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

Hettmer, S
Linardic, CM
Kelsey, A
Rudzinski, ER
Vokuhl, C
Selfe, J
Ruhen, O
Shern, JF
Khan, J
Kovach, AR
Lupo, PJ
Gatz, SA
Schäfer, BW
Volchenboum, S
Minard-Colin, V
Koscielniak, E
Hawkins, DS
Bisogno, G
Sparber-Sauer, M
Venkatramani, R
Merks, JHM
Shipley, J

September 2022

Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas in children/adolescents less than ...

t(11;22)(q24;q12) in rhabdomyosarcomas (RMS)

Huret, JL

January 2011

Review on t(11;22)(q24;q12) in rhabdomyosarcomas (RMS), with data on clinics, and the genes involved

Soft tissue tumors: Rhabdomyosarcoma

Couturier, J

January 1998

Review on Soft tissue tumors: Rhabdomyosarcoma, with data on clinics, and the genes involved

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Carina A. Dehner
Amy E. Armstrong
Marielle Yohe
Jack F. Shern
Angela C. Hirbe

September 2021

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents and accoun...

Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.

Walther, Charles
Mayrhofer, Markus
Nilsson, Jenny
Hofvander, Jakob
Jonson, Tord
Mandahl, Nils
Øra, Ingrid
Gisselsson Nord, David
Mertens, Fredrik

January 2016

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents. Alveolar ...

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Missiaglia, E.
Williamson, D.
Chisholm, J.
Wirapati, P.
Pierron, G.
Petel, F.
Concordet, J.P.
Thway, K.
Oberlin, O.
Pritchard-Jones, K.
Delattre, O.
Delorenzi, M.
Shipley, J.

January 2012

PURPOSE: To improve the risk stratification of patients with rhabdomyosarcoma (RMS) through the use ...

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

Hettmer, Simone
Linardic, Corinne M
Kelsey, Anna
Rudzinski, Erin R
Vokuhl, Christian
Selfe, Joanna
Ruhen, Olivia
Shern, Jack F
Khan, Javed
Kovach, Alexander R
Lupo, Philip J
Gatz, Susanne A
Schäfer, Beat W
Volchenboum, Samuel
Minard-Colin, Véronique
Koscielniak, Ewa
Hawkins, Douglas S
Bisogno, Gianni
Sparber-Sauer, Monika
Venkatramani, Rajkumar
Merks, Johannes H M
Shipley, Janet

September 2022

Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas in children/adolescents less than ...

Clonality and evolutionary history of rhabdomyosarcoma.

Chen, L
Shern, JF
Wei, JS
Yohe, ME
Song, YK
Hurd, L
Liao, H
Catchpoole, D
Skapek, SX
Barr, FG
Hawkins, DS
Khan, J

April 2022

To infer the subclonality of rhabdomyosarcoma (RMS) and predict the temporal order of genetic events...

Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.

Hingorani, P.
Missiaglia, E.
Shipley, J.
Anderson, J.R.
Triche, T.J.
Delorenzi, M.
Gastier-Foster, J.
Wing, M.
Hawkins, D.S.
Skapek, S.X.

January 2015

PURPOSE: Pediatric rhabdomyosarcoma (RMS) has two common histologic subtypes: embryonal (ERMS) and a...

Impact of fusion gene status versus histology on riskâ stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials

Selfe, Joanna
Olmos, David
Al‐saadi, Reem
Thway, Khin
Chisholm, Julia
Kelsey, Anna
Shipley, Janet

July 2017

BackgroundLongâ term toxicities from current treatments are a major issue in paediatric cancer. Pre...

Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies

Hettmer, S.
Li, Z.
Billin, A. N.
Barr, F. G.
Cornelison, D. D.
Ehrlich, A. R.
Guttridge, D. C.
Hayes-Jordan, A.
Helman, L. J.
Houghton, P. J.
Khan, J.
Langenau, D. M.
Linardic, C. M.
Pal, R.
Partridge, T. A.
Pavlath, G. K.
Rota, R.
Schafer, B. W.
Shipley, J.
Stillman, B.
Wexler, L. H.
Wagers, A. J.
Keller, C.

November 2014

Rhabdomyosarcoma (RMS) represents a rare, heterogeneous group of mesodermal malignancies with skelet...

Rhabdomyosarcoma (RMS): Insights into Epidemiology, Molecular Classification, Therapeutic Advances, and Future Directions

Cardenas Aguirre, Carlos Alberto

October 2023

Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, represents a formidable cha...

Rhabdomyosarcoma: Current challenges and their implications for developing therapies

Hettmer, Simone
Li, Zhizhong
Billin, Andrew N
Barr, Frederic G
Cornelison, D D W
Ehrlich, Alan R
Guttridge, Denis C
Hayes-Jordan, Andrea
Helman, Lee J
Houghton, Peter J
Khan, Javed
Langenau, David M
Linardic, Corinne M
Pal, Ranadip
Partridge, Terence A
Pavlath, Grace K
Rota, Rossella
Schäfer, Beat W
Shipley, Janet
Stillman, Bruce
Wexler, Leonard H
Wagers, Amy J
Keller, Charles

January 2014

Rhabdomyosarcoma (RMS) represents a rare, heterogeneous group of mesodermal malignancies with skelet...

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis A Report from the Children's Oncology Group

Davicioni, Elai
Anderson, Michael J.
Finckenstein, Friedrich Graf
Lynch, James C.
Qualman, Stephen J.
Shimada, Hiroyuki
Schofield, Deborah E.
Buckley, Jonathan D.
Meyer, William H.
Sorensen, Poul H.B.
Triche, Timothy J.

February 2009

Rhabdomyosarcoma (RMS) in children occurs as two major histological subtypes, embryonal (ERMS) and a...

Current and future treatment strategies for rhabdomyosarcoma

Chen, C.
Dorado-Garcia, H.
Scheer, M.
Henssen, A.G.

December 2019

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, and can be subcategorized...

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

Hettmer, S
Linardic, CM
Kelsey, A
Rudzinski, ER
Vokuhl, C
Selfe, J
Ruhen, O
Shern, JF
Khan, J
Kovach, AR
Lupo, PJ
Gatz, SA
Schäfer, BW
Volchenboum, S
Minard-Colin, V
Koscielniak, E
Hawkins, DS
Bisogno, G
Sparber-Sauer, M
Venkatramani, R
Merks, JHM
Shipley, J

September 2022

Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas in children/adolescents less than ...

t(11;22)(q24;q12) in rhabdomyosarcomas (RMS)

Huret, JL

January 2011

Review on t(11;22)(q24;q12) in rhabdomyosarcomas (RMS), with data on clinics, and the genes involved

Soft tissue tumors: Rhabdomyosarcoma

Couturier, J

January 1998

Review on Soft tissue tumors: Rhabdomyosarcoma, with data on clinics, and the genes involved

Genetic characterization, current model systems and prognostic stratification in PAX fusion-negative vs. PAX fusion-positive rhabdomyosarcoma

Abstract

Extracted data

Genetic characterization, current model systems and prognostic stratification in PAX fusion-negative vs. PAX fusion-positive rhabdomyosarcoma

Abstract

Extracted data

Related items

Related items